Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older

NCT01236001 · clinicaltrials.gov ↗
COMPLETED
Status
192
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

UCB Pharma